AmCham represents the interests of its members, making membership a valuable asset.
Matiss Kukainis, Partner at Spigulis & Kukainis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com Novartis operates in Latvia since 1996. We are amongst top pharmaceutical companies by sales value and clinical trial sponsors in Latvia.
Being part of AmCham is a great way to maintain business contacts with entrepreneurs and professionals.
Normunds Bergs, Chief Executive Officer, SAF Tehnika